Selective B cell depletion upon intravenous infusion of replication-incompetent anti-CD19 CAR lentivirus

Autor: Rive, Craig M., Yung, Eric, Dreolini, Lisa, Brown, Scott D., May, Christopher G., Woodsworth, Daniel J., Holt, Robert A.

Publikováno v: In Molecular Therapy - Methods & Clinical Development 8 September 2022 26:4-14

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Testing for Drug Hypersensitivity Syndromes

Autor: Rive, Craig M, Bourke, Jack, Phillips, Elizabeth J

Adverse drug reactions are a common cause of patient morbidity and mortality. Type B drug reactions comprise only 20% of all drug reactions but they tend to be primarily immunologically mediated and less dependent on the drug's pharmacological action

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::ca841f4bfcf5d831013fe79ee01f9e1d
https://europepmc.org/articles/PMC3626363/

Identification of a CD8+ T-cell response to a predicted neoantigen in malignant mesothelioma.

Autor: Sneddon S; National Centre for Asbestos Related Disease, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Australia., Rive CM; National Centre for Asbestos Related Disease, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Australia., Ma S; National Centre for Asbestos Related Disease, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Australia., Dick IM; National Centre for Asbestos Related Disease, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Australia., Allcock RJN; Pathwest Laboratory Medicine, Western Australia, QEII Medical Centre, Nedlands, Australia.; School of Biomedical Sciences, University of Western Australia, Nedlands, Australia., Brown SD; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada., Holt RA; Michael Smith Genome Sciences Centre, BC Cancer, Vancouver, British Columbia, Canada., Watson M; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia., Leary S; Institute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Australia., Lee YCG; National Centre for Asbestos Related Disease, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Australia.; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Australia., Robinson BWS; National Centre for Asbestos Related Disease, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Australia.; Department of Respiratory Medicine, Sir Charles Gairdner Hospital, Nedlands, Australia., Creaney J; National Centre for Asbestos Related Disease, School of Medicine and Pharmacology, University of Western Australia, Nedlands, Australia.

Publikováno v: Oncoimmunology [Oncoimmunology] 2019 Nov 03; Vol. 9 (1), pp. 1684713. Date of Electronic Publication: 2019 Nov 03 (Print Publication: 2020).